Increased intravascular platelet activity in metabolic syndrome patients, and its correction by simvastatin treatment
Simvastatin treatment in patients with arterial hypertension (AH) and metabolic syndrome (MS) corrects dyslipoproteinemia, peroxidation syndrome, and optimizes platelet homeostasis. Simvastatin inhibits increased intravascular platelet activity in vivo. For stable correction of metabolism and platel...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2004-12-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/2312 |